These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 33434501)

  • 41. Acute Respiratory Failure Outcomes in Patients with Hematologic Malignancies and Hematopoietic Cell Transplant: A Secondary Analysis of the EFRAIM Study.
    Munshi L; Darmon M; Soares M; Pickkers P; Bauer P; Meert AP; Martin-Loeches I; Staudinger T; Pene F; Antonelli M; Barratt-Due A; Demoule A; Metaxa V; Lemiale V; Taccone F; Mokart D; Azoulay E; Mehta S;
    Transplant Cell Ther; 2021 Jan; 27(1):78.e1-78.e6. PubMed ID: 33011289
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Clinical Characteristics and Risk Factors of Diffuse Alveolar Hemorrhage in Systemic Lupus Erythematosus: a Systematic Review and Meta-Analysis Based on Observational Studies.
    Xu T; Zhang G; Lin H; Xie Y; Feng Y; Zhang X; Dong G
    Clin Rev Allergy Immunol; 2020 Dec; 59(3):295-303. PubMed ID: 31440948
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Characteristics and Prognosis of Microscopic Polyangiitis Patients with Diffuse Alveolar Hemorrhage and Interstitial Lung Disease.
    Gu Y; Zhang T; Peng M; Shi JH
    Chin Med Sci J; 2022 Dec; 37(4):293-302. PubMed ID: 36000390
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Low-Dose Antithymocyte Globulin for Graft-versus-Host-Disease Prophylaxis in Matched Unrelated Allogeneic Hematopoietic Stem Cell Transplantation.
    Bryant A; Mallick R; Huebsch L; Allan D; Atkins H; Anstee G; Sabloff M; Scrivens N; Maze D; Bredeson C; Kekre N
    Biol Blood Marrow Transplant; 2017 Dec; 23(12):2096-2101. PubMed ID: 28821454
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Diffuse Alveolar Hemorrhage: A Cohort of Patients With Systemic Lupus Erythematosus.
    Quintana JH; Aragón CC; Santos VA; de Las Salas A; Tafúr RA; Aguirre-Valencia D; Cañas CA; Tobón GJ
    J Clin Rheumatol; 2020 Oct; 26(7S Suppl 2):S153-S157. PubMed ID: 31895107
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Analysis of risk factors associated with diffuse alveolar haemorrhage in patients with ANCA-associated vasculitis and construction of a risk prediction model using line graph.
    Li X; Ma C; Xu J; Zhang M; Xiang Q; Li Y; Li W; Zhu P
    Clin Exp Rheumatol; 2024 Apr; 42(4):864-871. PubMed ID: 38634373
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A multicenter investigation of respiratory syncytial viral infection in children with hematopoietic cell transplantation.
    Rowan CM; Gertz SJ; Zinter MS; Moffet J; Bajwa RPS; Barnum JL; Kong M;
    Transpl Infect Dis; 2018 Jun; 20(3):e12882. PubMed ID: 29573141
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Validation of the Hematopoietic Cell Transplantation-Specific Comorbidity Index in Nonmyeloablative Allogeneic Stem Cell Transplantation.
    Veeraputhiran M; Yang L; Sundaram V; Arai S; Lowsky R; Miklos D; Meyer E; Muffly L; Negrin R; Rezvani A; Shizuru J; Weng WK; Johnston L
    Biol Blood Marrow Transplant; 2017 Oct; 23(10):1744-1748. PubMed ID: 28668491
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Age Adjusted Comorbidity Risk Index Does Not Predict Outcomes in an Autologous Hematopoietic Stem Cell Transplant Population.
    Barth D; Singleton M; Monohan G; McClune B; Adams V
    Cell Transplant; 2022; 31():9636897221080385. PubMed ID: 35225031
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Diffuse alveolar hemorrhage after allogeneic bone marrow transplantation].
    Ishida T; Arita M; Fujimori N
    Nihon Kyobu Shikkan Gakkai Zasshi; 1996 Mar; 34(3):369-73. PubMed ID: 8778482
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Severe diffuse alveolar hemorrhage related to autoimmune disease: a multicenter study.
    Mirouse A; Parrot A; Audigier V; Demoule A; Mayaux J; Géri G; Mariotte E; Bréchot N; de Prost N; Vautier M; Neuville M; Bigé N; de Montmollin E; Cacoub P; Resche-Rigon M; Cadranel J; Saadoun D
    Crit Care; 2020 May; 24(1):231. PubMed ID: 32423434
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Invasive aspergillosis following hematopoietic cell transplantation: outcomes and prognostic factors associated with mortality.
    Upton A; Kirby KA; Carpenter P; Boeckh M; Marr KA
    Clin Infect Dis; 2007 Feb; 44(4):531-40. PubMed ID: 17243056
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hematopoietic Cell Transplant-Composite Risk (HCT-CR): A Novel Predictor of Prognosis in Acute Leukemia Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation.
    Yegin ZA; Özkurt ZN; Dikyar A; Kaynar LA; Karacaoğlu Ö; Yağcı M
    Transplant Proc; 2021; 53(6):2013-2020. PubMed ID: 34246474
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Diffuse alveolar hemorrhage in Colombian patients with systemic lupus erythematosus.
    Cañas C; Tobón GJ; Granados M; Fernández L
    Clin Rheumatol; 2007 Nov; 26(11):1947-9. PubMed ID: 17377738
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Epidemiology of Acute Respiratory Distress Syndrome Following Hematopoietic Stem Cell Transplantation.
    Yadav H; Nolan ME; Bohman JK; Cartin-Ceba R; Peters SG; Hogan WJ; Gajic O; Kor DJ
    Crit Care Med; 2016 Jun; 44(6):1082-90. PubMed ID: 26807683
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Evaluation of Performance Status and Hematopoietic Cell Transplantation Specific Comorbidity Index on Unplanned Admission Rates in Patients with Multiple Myeloma Undergoing Outpatient Autologous Stem Cell Transplantation.
    Obiozor C; Subramaniam DP; Divine C; Shune L; Singh AK; Lin TL; Abhyankar S; Chen GJ; McGuirk J; Ganguly S
    Biol Blood Marrow Transplant; 2017 Oct; 23(10):1641-1645. PubMed ID: 28603071
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Incidence, Risk Factors, and Outcomes of Idiopathic Pneumonia Syndrome after Allogeneic Hematopoietic Cell Transplantation.
    Wenger DS; Triplette M; Crothers K; Cheng GS; Hill JA; Milano F; Shahrir S; Schoch G; Vande Vusse LK
    Biol Blood Marrow Transplant; 2020 Feb; 26(2):413-420. PubMed ID: 31605819
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Defining incidence, risk factors, and impact on survival of central line-associated blood stream infections following hematopoietic cell transplantation in acute myeloid leukemia and myelodysplastic syndrome.
    Lukenbill J; Rybicki L; Sekeres MA; Zaman MO; Copelan A; Haddad H; Fraser T; DiGiorgio MJ; Hanna R; Duong H; Hill B; Kalaycio M; Sobecks R; Bolwell B; Copelan E
    Biol Blood Marrow Transplant; 2013 May; 19(5):720-4. PubMed ID: 23380342
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A modified EBMT risk score and the hematopoietic cell transplantation-specific comorbidity index for pre-transplant risk assessment in adult acute lymphoblastic leukemia.
    Terwey TH; Hemmati PG; Martus P; Dietz E; Vuong LG; Massenkeil G; Dörken B; Arnold R
    Haematologica; 2010 May; 95(5):810-8. PubMed ID: 20007143
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hematopoietic cell transplantation comorbidity index (HCT-CI) is predictive of adverse events and overall survival in older allogeneic transplant recipients.
    Keller JW; Andreadis C; Damon LE; Kaplan LD; Martin TG; Wolf JL; Ai WZ; Venstrom JM; Smith CC; Gaensler KM; Hwang J; Olin RL
    J Geriatr Oncol; 2014 Jul; 5(3):238-44. PubMed ID: 24894413
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.